Losartan, an angiotensin type 1 receptor inhibitor, and endothelial vasodilator function in Type 1 diabetes mellitus.
Collis
J
J
Cheetham
C
C
Dembo
L
L
O'Driscoll
J
J
Stanton
K
K
Taylor
R
R
Green
D
D
D000109:Acetylcholine / Q000494:pharmacology; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D018592:Cross-Over Studies; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology*; D004311:Double-Blind Method; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology*; D005260:Female; D005542:Forearm / Q000098:blood supply; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009599:Nitroprusside / Q000494:pharmacology; D010919:Placebos; D012039:Regional Blood Flow / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects*
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D010919:Placebos; D009599:Nitroprusside; D019808:Losartan; D000109:Acetylcholine